Korean biopharmaceutical firms join hands with foreign partners via technology transfer

Published: 2007-01-03 06:59:00

Updated: 2007-01-03 06:59:00

Some Korean biopharmaceutical companies have teamed up with foreign partners in the biotechnology sector via technology tie-ups and joint research collaboration, according to the Korea Health Industry Development Industry (KHIDI).

Angiolab signed a contract with an Australian company to commer...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK